Edition:
United States

Benitec Biopharma Ltd (BNTC.OQ)

BNTC.OQ on NASDAQ Stock Exchange Capital Market

2.06USD
4:00pm EDT
Change (% chg)

$-0.12 (-5.50%)
Prev Close
$2.18
Open
$2.03
Day's High
$2.10
Day's Low
$2.02
Volume
1,210
Avg. Vol
2,443
52-wk High
$4.15
52-wk Low
$1.85

Latest Key Developments (Source: Significant Developments)

Benitec Biopharma ‍Says U.S. FDA Granted Orphan Drug Designation To BB-301​
Sunday, 14 Jan 2018 04:57pm EST 

Jan 15 (Reuters) - Benitec Biopharma Ltd ::‍U.S. FDA HAS GRANTED ORPHAN DRUG DESIGNATION TO BB-301 FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY(OPMD)​.  Full Article

Benitec Biopharma Posts Qtrly ‍Loss Of A$2.9 mln
Tuesday, 28 Nov 2017 11:38pm EST 

Nov 29 (Reuters) - Benitec Biopharma Ltd ::QTRLY ‍LOSS OF A$2.9 MILLION VERSUS PROFIT OF A$0.8 MILLION​.  Full Article

Benitec biopharma signs new research and collaboration agreement
Wednesday, 21 Dec 2016 05:42pm EST 

Benitec Biopharma Ltd :New research and collaboration agreement has been signed with royal holloway university of london.  Full Article

Benitec Biopharma says Greg West appointed CEO
Wednesday, 10 Aug 2016 05:00am EDT 

Benitec Biopharma Ltd : Says Bryan Dulhunty appointed CFO .Cliff Holloway appointed CBO and COO.  Full Article

Benitec Biopharma appoints Greg West as chief executive officer
Tuesday, 9 Aug 2016 07:32pm EDT 

Benitec Biopharma Ltd : Restructuring of senior executive team . Says appointment of Greg West as chief executive officer .Bryan Dulhunty appointed as CFO.  Full Article

BRIEF-Benitec Biopharma Launches Entitlement Offer And Placement

* LAUNCHED ENTITLEMENT OFFER TO ELIGIBLE SHAREHOLDERS AND INSTITUTIONAL PLACEMENT TO HIGHBRIDGE CAPITAL MANAGEMENT LLC